Because CD44 plays a pivotal role in promoting tumor metastasis and conferring resistance to therapy, multiple therapeutic strategies have been designed to target CD44 against various cancers, including breast, head and neck, ovarian, and gynecological cancers [37]. Here, CD44 is linked to cancer.